Ignite Creation Date:
2024-05-06 @ 3:27 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04631757
Status:
UNKNOWN
Last Update Posted:
2020-11-17
First Post:
2020-11-15
Brief Title:
Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction GEJ Adenocarcinoma
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Gastric Cancer |
Keywords: